EVANSTON, Ill., Oct. 9 /PRNewswire/ -- Northfield Laboratories Inc.
(Nasdaq: NFLD), a leading developer of an oxygen-carrying blood substitute for
trauma and elective surgery applications, will host its annual meeting this
Thursday, October 12, 2000, at 9:00 a.m. Central Time. Following the business
matters described in Northfield's proxy material, a discussion of the
company's performance and prospects will be held online at 10:00 a.m.
Access to this presentation will only be available electronically or by
telephone. Interested parties may log on to http://www.vcall.com or
http://www.northfieldlabs.com at the designated time. The toll-free conference call
dial-in number is 800-982-3654 for those wishing to listen via telephone. The
online conference will allow shareholders to simultaneously receive an update
on the company and access to management's remarks.
Northfield Laboratories was founded in 1985. The company is headquartered
in Evanston, Illinois, and its stock is traded on the Nasdaq National Market
System under the symbol NFLD.
Statements in this release that are not strictly historical are "forward-
looking" statements that are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Forward-looking
statements involve known and unknown risks, which may cause the company's
actual results in the future to differ materially from expected results.
These risks include, among others: competition from other blood substitute
products; the company's ability to obtain regulatory approval to market
PolyHeme commercially; the company's ability to successfully market and sell
PolyHeme; the company's ability to manufacture PolyHeme in sufficient
quantities; the company's ability to obtain an adequate supply of raw
materials; the company's ability to maintain intellectual property protection
for its proprietary product and to defend its existing intellectual property
rights from challenges by third parties; the availability of capital to
finance planned growth; and the extent to which the hospitals and physicians
using PolyHeme are able to obtain third-party reimbursement, as described in
the company's filing with the Securities and Exchange Commission.
For more information on Northfield Laboratories Inc. via facsimile at no
cost, simply dial 1-800-PRO-INFO and enter the company code NFLD.
Visit the Northfield website at: http://www.northfieldlabs.com .
SOURCE Northfield Laboratories Inc.
 back to top
Related links:
http://www.northfieldlabs.com
CONTACT:
Richard DeWoskin, Chief Executive Officer of
Northfield Laboratories, 847-864-3500; or General, Leslie
Hunziker of The Financial Relations Board, 312-266-7800
|
